---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-010195"
form_type: "8-K"
ticker: "IMNN"
cik: "0000749647"
company_name: "Imunon, Inc."
filed_at: "2024-03-18T23:59:59+00:00"
generated_at: "2026-06-04T16:18:33.456937+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Imunon amends bylaws to revise voting thresholds and adjournment procedures per DGCL changes

## Summary
- Board approved amendments effective March 15, 2024; Amended and Restated Bylaws filed as Exhibit 3.1.
- Amendments revise voting thresholds required for stockholder approval of certain matters.
- Adjournment procedures for stockholder meetings modified to reflect recent changes to Delaware General Corporation Law.
- Periodic bylaw review triggered by recent DGCL amendments; changes became immediately effective.

## SEC filing metadata
- accession: 0001493152-24-010195
- form_type: 8-K
- ticker: IMNN
- cik: 0000749647
- company_name: Imunon, Inc.
- filed_at: 2024-03-18T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/749647/000149315224010195/0001493152-24-010195-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/749647/000149315224010195/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-010195
- JSON: https://secwatch.observer/filing/0001493152-24-010195.json
- Plain text: https://secwatch.observer/filing/0001493152-24-010195.txt

## Key facts
- Governance Changes
  Imunon, Inc.: Amended and Restated Bylaws to revise voting thresholds for stockholder approval and modify adjournment procedures for stockholder meetings to reflect DGCL amendments (effective 2024-03-15).
  - Change: bylaw amendment
  - Effective: 2024-03-15
  source text: On March 15, 2024, in connection with certain recent changes to the Delaware General Corporation Law (the “ DGCL ”), and a periodic review of the bylaws of Imunon, Inc. (the “ Company ”), the Company’s Board of Directors approved and adopted certain amendments to the Company’s bylaws (as amended to date, the “ Amended and Restated Bylaws ”), which became immediately effective.
  evidence_url: https://www.sec.gov/Archives/edgar/data/749647/000149315224010195/0001493152-24-010195-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
